Pediatric rheumatology has seen significant advancements in the past decade, with new diagnostic tools and therapeutic approaches transforming patient care. Juvenile idiopathic arthritis (JIA) and other autoimmune diseases in children present unique challenges, requiring early intervention to prevent long-term disability. The development of novel biomarkers, imaging techniques, and personalized treatment strategies has improved disease classification and management. Moreover, biologic therapies and targeted immunomodulatory treatments have revolutionized outcomes for children with severe and refractory disease. Despite these advances, there remain gaps in understanding disease pathophysiology, response to treatment, and long-term prognosis. This Research Topic aims to explore recent breakthroughs in pediatric rheumatology, highlighting emerging trends and their impact on clinical practice.
The primary objective of this Research Topic is to showcase cutting-edge developments in pediatric rheumatology, with a focus on improving early diagnosis, optimizing treatment strategies, and enhancing long-term patient outcomes. We aim to address key challenges such as disease heterogeneity, treatment resistance, and the role of genetic and environmental factors in disease progression. By bringing together experts in the field, this collection will highlight the latest research on novel biomarkers, imaging advancements, and therapeutic innovations, including biologics and small-molecule inhibitors. Additionally, the topic will cover the evolving role of disease monitoring tools and real-world data in guiding treatment decisions. Through interdisciplinary collaboration, we hope to pave the way for precision medicine approaches tailored to pediatric patients, ultimately improving their quality of life.
This Research Topic invites original research articles, reviews, and case reports focusing on novel insights into pediatric rheumatologic conditions. Areas of interest include: Advances in early diagnosis and classification of pediatric autoimmune diseases, Biomarkers and genetic predictors of disease progression and treatment response, Innovative therapeutic approaches, including biologics and targeted therapies, Application of imaging and disease monitoring tools in clinical practice, Long-term outcomes and quality of life in pediatric rheumatology patients
We encourage contributions from clinicians, researchers, and industry professionals to provide a comprehensive overview of recent discoveries and future directions in the field.
Article types and fees
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Case Report
Classification
Clinical Trial
Data Report
Editorial
FAIR² Data
General Commentary
Hypothesis and Theory
Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.
Article types
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
